Therapy Areas: Cardiovascular
Medicure reports financial results for nine months ended 30 September 2020
12 November 2020 -

Medicure Inc (TSXV:MPH) (OTC:MCUJF), a cardiovascular pharmaceutical company, announced on Wednesday its financial results for the nine months ended 30 September 2020.

The company's reported adjusted EBITDA for the nine months ended 30 September 2020 was negative USD1m, compared to negative USD1.9m for the same period in 2019.

The firm posted net loss for the nine months ended 30 September 2020 at USD2.5m or USD0.23 per share, compared to a net loss of USD4.3m or USD0.28 per share for the nine months ended 30 September 2019.

Login
Username:

Password: